Midland States Bancorp, Inc.
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Report of Independent Registered Public Accounting Firm (PCAOB ID 173) | 55 |
|---|---|
| Consolidated Balance Sheets | 56 |
| Consolidated Statements of Income | 57 |
| Consolidated Statements of Comprehensive Income | 58 |
| Consolidated Statements of Shareholders' Equity | 59 |
| Consolidated Statements of Cash Flows | 60 |
| Note 1. Summary of Significant Accounting Policies | 61 |
| Note 2. Investment Securities | 71 |
| Note 3. Loans | 73 |
| Note 4. Premises, Equipment and Leases | 90 |
| Note 5: Operating Leases - Lessor | 91 |
| Note 6. Loan Servicing Rights | 91 |
| Note 7. Goodwill and Intangible Assets | 92 |
| Note 8. Derivative Instruments | 93 |
| Note 9. Deposits | 96 |
| Note 10. FHLB Advances | 96 |
| Note 11. Subordinated Debt | 97 |
| Note 12. Trust Preferred Debentures | 98 |
| Note 13. Accumulated Other Comprehensive Income (Loss) | 99 |
| Note 14. Income Taxes | 100 |
| Note 15. Retirement Plans | 102 |
| Note 16. Share-Based Compensation | 104 |
| Note 17. Preferred Stock | 106 |
| Note 18. Earnings Per Common Share | 107 |
| Note 19. Capital Requirements | 107 |
| Note 20. Fair Value of Financial Instruments | 108 |
| Note 21. Commitments, Contingencies and Credit Risk | 114 |
| Note 22. Segment Information | 114 |
| Note 23. Revenue from Contracts with Customers | 117 |
| Note 24. Parent Company Only Financial Information | 118 |
Shareholders and the Board of Directors of Midland States Bancorp, Inc.
Effingham, Illinois
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of Midland States Bancorp, Inc. (the "Company") as of December 31, 2025 and 2024, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2025, and the related notes (collectively referred to as the "financial statements"). We also have audited the Company’s internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control – Integrated Framework: (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2025 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control – Integrated Framework: (2013) issued by COSO.
Basis for Opinions
The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
As described in Notes 1 and 3 to the consolidated financial statements, the Allowance for Credit Losses on Loans (“ACL”) represents the Company’s estimate of expected credit losses over the contractual life of loans held for investment. The estimate is based on historical loss experience, current conditions, and reasonable and supportable forecasts. As of December 31, 2025, the Company’s ACL was $69.2 million, and the provision for credit losses on loans was $60.5 million for the year then ended.
The Company estimates expected credit losses using a quantitative model and qualitative adjustments. The quantitative component is based on a probability of default, loss given default, and exposure at default framework that incorporates historical default experience, loan-level risk characteristics, and forecasted macroeconomic variables over a reasonable and supportable forecast period, with losses reverting to long-term historical averages thereafter. The macroeconomic variables used in the model are selected based on statistical relevancy and correlation to historical credit losses by performing regression analyses. Management then applies qualitative factor adjustments to the modeled results for risks not fully captured in the model, including changes in economic and business conditions, portfolio credit quality, delinquency and nonaccrual trends, collateral values, and other internal and external factors.
We identified auditing the allowance for credit losses on loans, including the selection and application of forecasted macroeconomic variables and qualitative factor adjustments, as a critical audit matter. Auditing these judgments involved a high degree of auditor judgment and significant audit effort to evaluate the significant subjective and complex judgments made by management throughout the application processes for the forecasted macroeconomic variables and qualitative factor adjustments, including the need to involve our valuation services specialists.
The primary audit procedures we performed to address this critical audit matter included:
Testing the operating effectiveness of the Company’s controls over the:
Selection and application of forecasted macroeconomic variables and related forecast scenarios.
Review of the reasonableness of the calculation output and tested the completeness and accuracy of inputs used in the quantitative model and qualitative factor adjustments.
Review over the relevance and reliability of external data used in the analysis to select the forecasted macroeconomic variables and qualitative factor adjustments.
Review over the appropriateness of the framework for the qualitative factor adjustments.
Mathematical accuracy of the qualitative factor adjustments.
Substantive tests included:
Evaluating the relevance and reliability of the external data used in the selection of forecasted macroeconomic variables.
Evaluating the reasonableness of the selection and application of the forecasted macroeconomic variables and scenarios used in the reasonable and supportable forecast period.
Testing the completeness and accuracy of inputs used in the quantitative model and evaluating the reasonableness of the calculation output.
Assessing the appropriateness and reasonableness of the framework developed for the qualitative factor adjustments including evaluating management’s judgments as to which factors impacted the qualitative analysis for each portfolio segment.
Testing the completeness and accuracy of internal data and relevance and reliability of external data used in determining the qualitative factor adjustments.
Testing the mathematical accuracy of the calculation of the qualitative factor adjustments.
Credit Enhancements Contained Within Third-Party Agreements
The Company has an agreement with a third party to originate and service consumer and commercial loans that are included in the Company’s loan portfolio as described in Notes 1 and 3 to the consolidated financial statements. The Company recorded a credit enhancement asset of $12.6 million as of December 31, 2025 related to the agreement associated with loans recorded on the balance sheet as of December 31, 2025. The Company also recorded a $12.6 million allowance for credit losses for these consumer and commercial loans as of December 31, 2025.
We identified auditing the accounting associated with the credit enhancement contained within the third-party agreements as a critical audit matter due to the nature and extent of audit effort required, including the need for individuals with specialized knowledge.
The primary procedures we performed to address this critical audit matter included engaging our internal specialists to evaluate the third-party agreement and the related accounting treatment; and testing the operating effectiveness of the control over the evaluation of the accounting and financial reporting impact related to this third-party agreement.
Crowe LLP
We have served as the Company’s auditor since 2017.
Oakbrook Terrace, Illinois
March 2, 2026
CONSOLIDATED BALANCE SHEETS
| December 31,2025 | December 31,2024 | |
|---|---|---|
| Assets | ||
| Cash and due from banks | $127,279 | $114,055 |
| Federal funds sold | 532 | 711 |
| Cash and cash equivalents | 127,811 | 114,766 |
| Investment securities available for sale, at fair value | 1,523,001 | 1,207,574 |
| Equity securities, at fair value | 4,235 | 4,792 |
| Loans | 4,352,004 | 5,167,574 |
| Allowance for credit losses on loans | (69,219) | (111,204) |
| Total loans, net | 4,282,785 | 5,056,370 |
| Loans held for sale | 7,781 | 344,947 |
| Premises and equipment, net | 85,134 | 85,710 |
| Other real estate owned | 606 | 4,941 |
| Nonmarketable equity securities | 32,598 | 33,723 |
| Accrued interest receivable | 23,824 | 25,329 |
| Loan servicing rights, at lower of cost or fair value | 11,932 | 17,842 |
| Loan servicing rights, held for sale | 3,661 | — |
| Goodwill | 7,927 | 161,904 |
| Other intangible assets, net | 8,876 | 12,100 |
| Company-owned life insurance | 218,554 | 211,168 |
| Credit enhancement asset | 12,557 | 16,804 |
| Other assets | 162,138 | 208,839 |
| Total assets | $6,513,420 | $7,506,809 |
| Liabilities and Shareholders’ Equity | ||
| Liabilities: | ||
| Deposits: | ||
| Noninterest-bearing demand deposits | $1,040,411 | $1,055,564 |
| Interest-bearing deposits | 4,383,968 | 5,141,679 |
| Total deposits | 5,424,379 | 6,197,243 |
| Short-term borrowings | 60,181 | 87,499 |
| Federal Home Loan Bank advances | 293,000 | 258,000 |
| Subordinated debt | 27,019 | 77,749 |
| Trust preferred debentures | 51,857 | 51,205 |
| Accrued interest payable and other liabilities | 91,485 | 124,266 |
| Total liabilities | 5,947,921 | 6,795,962 |
| Shareholders’ Equity: | ||
| Preferred stock, $2.00 par value; 4,000,000 shares authorized; 115,000 Series A shares, $1,000 per share liquidation preference, issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 110,548 | 110,548 |
| Common stock, $0.01 par value; 40,000,000 shares authorized; 21,169,854 and 21,494,485 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 212 | 215 |
| Capital surplus | 428,247 | 434,346 |
| Retained earnings | 86,825 | 247,698 |
| Accumulated other comprehensive loss, net of tax | (60,333) | (81,960) |
| Total shareholders’ equity | 565,499 | 710,847 |
| Total liabilities and shareholders’ equity | $6,513,420 | $7,506,809 |
CONSOLIDATED STATEMENTS OF INCOME
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Interest income: | |||
| Loans including fees: | |||
| Taxable | $310,169 | $365,892 | $378,333 |
| Tax exempt | 1,651 | 1,536 | 1,764 |
| Loans held for sale | 5,232 | 392 | 260 |
| Investment securities: | |||
| Taxable | 63,248 | 49,769 | 28,653 |
| Tax exempt | 1,753 | 1,511 | 1,349 |
| Nonmarketable equity securities | 2,729 | 3,070 | 2,819 |
| Federal funds sold and cash investments | 3,085 | 3,958 | 3,922 |
| Total interest income | 387,867 | 426,128 | 417,100 |
| Interest expense: | |||
| Deposits | 124,271 | 160,676 | 136,947 |
| Short-term borrowings | 2,807 | 1,960 | 68 |
| Federal Home Loan Bank advances | 14,621 | 16,495 | 20,709 |
| Subordinated debt | 4,554 | 5,271 | 5,266 |
| Trust preferred debentures | 4,810 | 5,380 | 5,289 |
| Total interest expense | 151,063 | 189,782 | 168,279 |
| Net interest income | 236,804 | 236,346 | 248,821 |
| Provision for credit losses: | |||
| Provision for credit losses on loans | 60,549 | 119,262 | 82,560 |
| (Recapture of) provision for credit losses on unfunded commitments | (700) | 1,070 | — |
| Total provision for credit losses | 59,849 | 120,332 | 82,560 |
| Net interest income after provision for credit losses | 176,955 | 116,014 | 166,261 |
| Noninterest income: | |||
| Wealth management revenue | 31,019 | 28,697 | 25,572 |
| Service charges on deposit accounts | 13,827 | 13,154 | 11,990 |
| Interchange revenue | 13,496 | 13,955 | 14,302 |
| Residential mortgage banking revenue | 2,857 | 2,418 | 1,903 |
| Income on company-owned life insurance | 8,564 | 7,683 | 4,439 |
| Gain (loss) on sales of investment securities, net | 14 | (230) | (9,372) |
| Credit enhancement income | 9,904 | 60,998 | 48,194 |
| Other income | 8,499 | 12,066 | 17,756 |
| Total noninterest income | 88,180 | 138,741 | 114,784 |
| Noninterest expense: | |||
| Salaries and employee benefits | 104,400 | 93,639 | 93,438 |
| Occupancy and equipment | 17,223 | 16,785 | 15,986 |
| Data processing | 27,974 | 28,160 | 26,286 |
| FDIC insurance | 8,136 | 5,278 | 4,779 |
| Professional services | 9,871 | 7,822 | 7,049 |
| Marketing | 5,861 | 3,926 | 3,158 |
| Communications | 1,376 | 1,364 | 1,741 |
| Loan expense | 6,992 | 5,954 | 4,206 |
| Loan servicing fees | 4,578 | 12,864 | 19,181 |
| Impairment on goodwill | 153,977 | — | — |
| Amortization of intangible assets | 3,224 | 4,008 | 4,758 |
| Other real estate owned | 281 | 5,569 | 333 |
| Loss on sale of loan portfolios | 23,051 | — | — |
| Impairment on leased assets and surrendered assets | 684 | 7,858 | — |
| Other expense | 12,375 | 14,628 | 12,168 |
| Total noninterest expense | 380,003 | 207,855 | 193,083 |
| Income (loss) before income taxes | (114,868) | 46,900 | 87,962 |
| Income tax expense | 9,413 | 8,856 | 26,807 |
| Net income (loss) | (124,281) | 38,044 | 61,155 |
| Preferred dividends | 8,913 | 8,913 | 8,913 |
| Net income (loss) available to common shareholders | $(133,194) | $29,131 | $52,242 |
| Per common share data: | |||
| Basic earnings (loss) per common share | $(6.12) | $1.32 | $2.33 |
| Diluted earnings (loss) per common share | $(6.12) | $1.32 | $2.33 |
| Weighted average common shares outstanding | 21,833,098 | 21,731,689 | 22,115,869 |
| Weighted average diluted common shares outstanding | 21,833,098 | 21,737,958 | 22,124,402 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(dollars in thousands)
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net income (loss) | $(124,281) | $38,044 | $61,155 |
| Other comprehensive income (loss): | |||
| Investment securities available for sale: | |||
| Unrealized gains that occurred during the period | 27,421 | (9,278) | (2,536) |
| Reclassification adjustment for realized net (gains) losses on sales of investment securities included in net income | (14) | 230 | 9,372 |
| Reclassification adjustment for gains on fair value hedges included in net income | — | (142) | — |
| Income tax effect | (7,603) | 1,677 | (1,845) |
| Change in investment securities available for sale, net of tax | 19,804 | (7,513) | 4,991 |
| Cash flow hedges: | |||
| Net unrealized derivative gains (losses) on cash flow hedges | 1,730 | (1,692) | (2,452) |
| Reclassification adjustment for net losses realized in net income | 693 | 4,891 | 5,264 |
| Income tax effect | (600) | (893) | (759) |
| Change in cash flow hedges, net of tax | 1,823 | 2,306 | 2,053 |
| Other comprehensive income (loss), net of tax | 21,627 | (5,207) | 7,044 |
| Total comprehensive income (loss) | $(102,654) | $32,837 | $68,199 |
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
| Preferred stock | Commonstock | Capitalsurplus | Retainedearnings | Accumulatedothercomprehensiveincome (loss) | Totalshareholders'equity | |
|---|---|---|---|---|---|---|
| Balances, December 31, 2022 | $110,548 | $222 | $449,196 | $219,970 | $(83,797) | $696,139 |
| Net income | — | — | — | 61,155 | — | 61,155 |
| Other comprehensive income | — | — | — | — | 7,044 | 7,044 |
| Issuance of preferred stock, net of offering costs | — | — | — | — | — | — |
| Common dividends declared ($1.20 per share) | — | — | — | (26,573) | — | (26,573) |
| Preferred dividends | — | — | — | (8,913) | — | (8,913) |
| Common stock repurchased | — | (8) | (17,890) | — | — | (17,898) |
| Share-based compensation expense | — | — | 2,489 | — | — | 2,489 |
| Issuance of common stock under employee benefit plans | — | 2 | 1,668 | — | — | 1,670 |
| Balances, December 31, 2023 | $110,548 | $216 | $435,463 | $245,639 | $(76,753) | $715,113 |
| Net income | — | — | — | 38,044 | — | 38,044 |
| Other comprehensive loss | — | — | — | — | (5,207) | (5,207) |
| Common dividends declared ($1.24 per share) | — | — | — | (27,072) | — | (27,072) |
| Preferred dividends | — | — | — | (8,913) | — | (8,913) |
| Common stock repurchased | — | (2) | (5,473) | — | — | (5,475) |
| Share-based compensation expense | — | — | 3,031 | — | — | 3,031 |
| Issuance of common stock under employee benefit plans | — | 1 | 1,325 | — | — | 1,326 |
| Balances, December 31, 2024 | $110,548 | $215 | $434,346 | $247,698 | $(81,960) | $710,847 |
| Net loss | — | — | — | (124,281) | — | (124,281) |
| Other comprehensive income | — | — | — | — | 21,627 | 21,627 |
| Common dividends declared ($1.26 per share) | — | — | — | (27,679) | — | (27,679) |
| Preferred dividends | — | — | — | (8,913) | — | (8,913) |
| Common stock repurchased | — | (4) | (9,654) | — | — | (9,658) |
| Share-based compensation expense | — | — | 2,913 | — | — | 2,913 |
| Issuance of common stock under employee benefit plans | — | 1 | 642 | — | — | 643 |
| Balances, December, 31, 2025 | $110,548 | $212 | $428,247 | $86,825 | $(60,333) | $565,499 |
CONSOLIDATED STATEMENTS OF CASH FLOWS
(dollars in thousands)
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash flows from operating activities: | |||
| Net income (loss) | $(124,281) | $38,044 | $61,155 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Provision for credit losses | 59,849 | 120,332 | 82,560 |
| Depreciation on premises and equipment | 4,892 | 4,993 | 4,778 |
| Impairment on goodwill | 153,977 | — | — |
| Amortization of intangible assets | 3,224 | 4,008 | 4,758 |
| Amortization of operating lease right-of-use asset | 1,570 | 1,657 | 1,635 |
| Amortization of loan servicing rights | 2,266 | 2,498 | 1,550 |
| Share-based compensation expense | 2,913 | 3,031 | 2,489 |
| Increase in cash surrender value of life insurance | (8,209) | (7,683) | (4,439) |
| Gain on proceeds from company-owned life insurance | (343) | — | — |
| Investment securities accretion, net | (13,696) | (6,789) | (2,414) |
| (Gain) loss on sales of investment securities, net | (14) | 230 | 9,372 |
| Gain on repurchase of subordinated debt | — | (231) | (676) |
| Gain on sales of other real estate owned | (124) | (26) | (819) |
| Impairment on other real estate owned | — | 4,866 | — |
| Origination of loans held for sale | (101,211) | (81,077) | (58,953) |
| Proceeds from sales of loans and leases held for sale | 133,534 | 78,514 | 57,952 |
| Gain on sale of loans held for sale | (2,560) | (2,307) | (2,395) |
| Loss on mortgage servicing rights held for sale | (18) | — | |
| Loss on sale of loan portfolios | 23,051 | — | — |
| Impairment on leased assets and surrendered assets | 684 | 7,858 | — |
| Net change in operating assets and liabilities: | |||
| Accrued interest receivable | 1,505 | 8,804 | (4,360) |
| Credit enhancement asset | 4,247 | (1,415) | (2,376) |
| Other assets | 24,483 | (16,783) | (24,038) |
| Accrued expenses and other liabilities | (40,060) | 18,022 | 27,579 |
| Net cash provided by operating activities | 125,679 | 176,546 | 153,358 |
| Cash flows from investing activities: | |||
| Purchases of investment securities available for sale | (622,913) | (605,169) | (412,799) |
| Proceeds from sales of investment securities available for sale | 103,758 | 74,116 | 191,733 |
| Maturities and payments on investment securities available for sale | 248,991 | 233,563 | 74,531 |
| Purchases of equity securities | (174) | (268) | (286) |
| Proceeds from sales of equity securities | — | — | 5,148 |
| Net decrease in loans | 438,907 | 346,883 | 72,877 |
| Proceeds from sales of consumer loans held for sale | 61,099 | — | — |
| Proceeds from sales of loan portfolios | 517,430 | 84,283 | 40,899 |
| Purchases of premises and equipment | (5,346) | (6,901) | (8,731) |
| Proceeds from sale of premises and equipment | — | 37 | 104 |
| Purchases of nonmarketable equity securities | (186,124) | (172,057) | (239,597) |
| Proceeds from redemptions of nonmarketable equity securities | 187,249 | 181,755 | 242,377 |
| Proceeds from sales of other real estate owned | 4,862 | 466 | 7,547 |
| Proceeds from company-owned life insurance, net | 1,166 | — | (48,603) |
| Net cash provided by (used in) investing activities | 748,905 | 136,708 | (74,800) |
| Cash flows from financing activities: | |||
| Net decrease in deposits | (772,864) | (112,286) | (55,123) |
| Net increase (decrease) in short-term borrowings | (27,318) | 52,634 | (7,446) |
| Net increase (decrease) in short-term FHLB advances | (20,000) | (166,000) | (174,000) |
| Proceeds from long-term FHLB advances | 328,000 | 263,000 | 215,000 |
| Payments made on long-term FHLB advances and other borrowings | (273,000) | (315,000) | (25,000) |
| Payments and subordinated debt redemption | (50,750) | (15,763) | (5,845) |
| Cash dividends paid on preferred stock | (8,913) | (8,913) | (8,913) |
| Cash dividends paid on common stock | (27,679) | (27,072) | (26,573) |
| Common stock repurchased | (9,658) | (5,475) | (17,898) |
| Proceeds from issuance of common stock under employee benefit plans | 643 | 1,326 | 1,670 |
| Net cash used in financing activities | (861,539) | (333,549) | (104,128) |
| Net increase (decrease) in cash and cash equivalents | 13,045 | (20,295) | (25,570) |
| Cash and cash equivalents: | |||
| Beginning of period | 114,766 | 135,061 | 160,631 |
| End of period | $127,811 | $114,766 | $135,061 |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.